National Academies Press: OpenBook

Issues in Risk Assessment (1993)

Chapter: 3.1 Empirical Correlations

« Previous: 2.4 Classification of Carcinogens
Suggested Citation:"3.1 Empirical Correlations." National Research Council. 1993. Issues in Risk Assessment. Washington, DC: The National Academies Press. doi: 10.17226/2078.
×

human carcinogen), Group 2B (possible human carcinogens), and Group 3 (unclassifiable with respect to human carcinogenicity).

Rosenkranz & Ennever (1990) also showed that genotoxic carcinogens that demonstrated mutagenic effects in the Salmonella assay were, on average, more potent than nongenotoxic carcinogens that tested negative in Salmonella. Human carcinogens also appear to be predominantly genotoxic (Shelby et al., 1988; Bartsch & Malaveille, 1989).

Based on an examination of the potency of carcinogens evaluated by the International Agency for Research on Cancer, McGregor (1992) concluded that there did not appear to be a strong association between carcinogenic potency in rodents and genotoxicity. It was noted that the most potent rodent carcinogen (TCDD) is apparently nongenotoxic, whereas one of the least potent rodent carcinogens (phenacetin) is mutagenic in the Salmonella assay.

3. Correlation Between TD50and the MTD
3.1 Empirical Correlations

Several investigators have noted a marked correlation between carcinogenic potency and the MDT (Bernstein et al., 1985; Gaylor, 1989; Krewski et al., 1989; Reith & Starr, 1989a). To demonstrate this relationship, we reanalyzed data in the CPDB on the 191 chemical carcinogens discussed in section 2.3. Following Gold et al. (1984), we first used the one-stage model to estimate the TD50 for each carcinogen based on the crude proportion of animals developing tumors at each dose (Figure 2a). To allow for curvilinear dose-response, the TD50 was also estimated using both the multistage and Weibull models (Figures 2b and 2c respectively). These estimates of carcinogenic potency values are all adjusted to a standard two year rodent lifetime as described in annex C. In each case, there is a strong positive association between the TD50 and the MDT, indicating that the most potent carcinogens in the database are those with the smallest MDTs.

The Pearson correlation coefficients between log10(TD50) and log10 (MDT) are 0.924, 0.952 or 0.821, depending on whether the one-stage, multistage or Weibull model is used to estimate the TD50. Note that the multistage model, which provides for curvature, yields a higher

Suggested Citation:"3.1 Empirical Correlations." National Research Council. 1993. Issues in Risk Assessment. Washington, DC: The National Academies Press. doi: 10.17226/2078.
×

FIGURE 2a Association between carcinogenic potency and maximum tolerated dose.

Suggested Citation:"3.1 Empirical Correlations." National Research Council. 1993. Issues in Risk Assessment. Washington, DC: The National Academies Press. doi: 10.17226/2078.
×

FIGURE 2b Association between carcinogenic potency and maximum tolerated dose.

Suggested Citation:"3.1 Empirical Correlations." National Research Council. 1993. Issues in Risk Assessment. Washington, DC: The National Academies Press. doi: 10.17226/2078.
×

FIGURE 2c Association between carcinogenic potency and maximum tolerated dose.

Suggested Citation:"3.1 Empirical Correlations." National Research Council. 1993. Issues in Risk Assessment. Washington, DC: The National Academies Press. doi: 10.17226/2078.
×
Page 121
Suggested Citation:"3.1 Empirical Correlations." National Research Council. 1993. Issues in Risk Assessment. Washington, DC: The National Academies Press. doi: 10.17226/2078.
×
Page 122
Suggested Citation:"3.1 Empirical Correlations." National Research Council. 1993. Issues in Risk Assessment. Washington, DC: The National Academies Press. doi: 10.17226/2078.
×
Page 123
Suggested Citation:"3.1 Empirical Correlations." National Research Council. 1993. Issues in Risk Assessment. Washington, DC: The National Academies Press. doi: 10.17226/2078.
×
Page 124
Next: 3.2 Range of Possible TD50 Values »
Issues in Risk Assessment Get This Book
×
Buy Paperback | $65.00
MyNAP members save 10% online.
Login or Register to save!
Download Free PDF

The scientific basis, inference assumptions, regulatory uses, and research needs in risk assessment are considered in this two-part volume.

The first part, Use of Maximum Tolerated Dose in Animal Bioassays for Carcinogenicity, focuses on whether the maximum tolerated dose should continue to be used in carcinogenesis bioassays. The committee considers several options for modifying current bioassay procedures.

The second part, Two-Stage Models of Carcinogenesis, stems from efforts to identify improved means of cancer risk assessment that have resulted in the development of a mathematical dose-response model based on a paradigm for the biologic phenomena thought to be associated with carcinogenesis.

  1. ×

    Welcome to OpenBook!

    You're looking at OpenBook, NAP.edu's online reading room since 1999. Based on feedback from you, our users, we've made some improvements that make it easier than ever to read thousands of publications on our website.

    Do you want to take a quick tour of the OpenBook's features?

    No Thanks Take a Tour »
  2. ×

    Show this book's table of contents, where you can jump to any chapter by name.

    « Back Next »
  3. ×

    ...or use these buttons to go back to the previous chapter or skip to the next one.

    « Back Next »
  4. ×

    Jump up to the previous page or down to the next one. Also, you can type in a page number and press Enter to go directly to that page in the book.

    « Back Next »
  5. ×

    Switch between the Original Pages, where you can read the report as it appeared in print, and Text Pages for the web version, where you can highlight and search the text.

    « Back Next »
  6. ×

    To search the entire text of this book, type in your search term here and press Enter.

    « Back Next »
  7. ×

    Share a link to this book page on your preferred social network or via email.

    « Back Next »
  8. ×

    View our suggested citation for this chapter.

    « Back Next »
  9. ×

    Ready to take your reading offline? Click here to buy this book in print or download it as a free PDF, if available.

    « Back Next »
Stay Connected!